DYNAMICS OF SST2 AND NT-PROBNP IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS BASED ON COMBINED THERAPY WITH EPLERENONE AND TRIMETASIDINE ADDITION

被引:0
|
作者
Bilovol, O. M. [1 ]
Kniazkova, I. I. [1 ]
Kirienko, O. M. [1 ]
Kuzminova, N. V. [2 ]
Sushetska, A. S. [1 ]
Starenkiy, V. P. [1 ]
Abramova, L. P. [1 ]
机构
[1] Kharkiv Natl Med Univ, Kharkiv, Ukraine
[2] Natl Pirogov Mem Med Univ, Vinnytsya, Ukraine
来源
WORLD OF MEDICINE AND BIOLOGY | 2023年 / 83卷 / 01期
关键词
soluble growth-stimulatingreceptor expressed by gene 2; N-terminal fragment of brain natriuretic propeptide; diastolic function; arterial hypertension; type 2 diabetes mellitus; eplerenone; trimetazidine; SOCIETY;
D O I
10.26724/2079-8334-2023-1-83-21-25
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The purpose of our study was to investigate the effect of complex therapy with the addition of eplerenone and trimetazidine on the state of left ventricular diastolic function, as well as levels of soluble growth-stimulatingreceptor expressed by gene 2 and N-terminal fragment of brain natriuretic propeptide in patients with arterial hypertension with type 2 diabetes mellitus. After registration baseline data were recorded, 42 patients (group 1) were prescribed baseline therapy and 38 patients (group 2) were prescribed eplerenone 25-50 mg once daily and trimetazidine 80 mg once daily in addition to antihypertensive therapy for 3 months. The control group consisted of 20 practically healthy individuals. After the treatment, a significant decrease in the level of soluble growth-stimulatingreceptor expressed by gene 2 in the blood of patients in both groups was found, but in group 2 this indicator did not differ from the control group, while in group 1 it remained significantly higher than in healthy individuals. At the same time, the level of N-terminal fragment of brain natriuretic propeptide significantly decreased by 1.3 times and 1.6 times in groups 1 and 2, respectively, but remained significantly higher than in the control group. A significant decrease E/e`mean was determined in both groups of patients, but in group 2 by 8.9 % less than in group 2 and a decrease in the geometric parameters of the left atrium, more pronounced in group 2. Thus, the addition of eplerenone and trimetazidine to the complex therapy of patients with arterial hypertension and type 2 diabetes mellitus during 3 months improved diastolic function, and also had a positive effect on the biomarker of myocardial stress and fibrosis soluble growth-stimulatingreceptor expressed by gene 2 level and myocardial dysfunction N-terminal fragment of brain natriuretic propeptide concentration in serum
引用
收藏
页码:21 / 25
页数:5
相关论文
共 50 条
  • [1] NT-proBNP in normoalbuminuric patients with Type 2 diabetes mellitus
    Andersen, NH
    Poulsen, SH
    Knudsen, ST
    Heickendorff, L
    Mogensen, CE
    DIABETIC MEDICINE, 2005, 22 (02) : 188 - 195
  • [2] NT-proBNP to Exclude cardiovascular Complications in Patients with Type 2 Diabetes mellitus
    Resl, Michael
    Neuhold, Stephanie
    Prager, Rudolf
    Brath, Helmut
    Francesconi, Claudia
    Luger, Anton
    Pacher, Richard
    Huelsmann, Martin
    Clodi, Martin
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S9 - S9
  • [3] NT-proBNP to Exclude cardiovascular Complications in Patients with Diabetes mellitus Type 2
    Resl, M.
    Huelsmann, M.
    Pacher, R.
    Luger, A.
    Clodi, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 (17-18) : 559 - 559
  • [4] Diagnostic values of NT-proBNP and sST2 in patients with acute coronary syndrome and heart failure
    Barnett, O. Olga
    Halkevych, M.
    Kyyak, Y.
    Labinska, O.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 106 - 106
  • [5] Levels of sST2 and NT-proBNP biomarkers in patients with acute coronary syndrome and subclinical hypothyroidism
    Kuz, N. B.
    Solomenchuk, T. M.
    ZAPOROZHYE MEDICAL JOURNAL, 2024, 26 (03) : 178 - 183
  • [6] CORRELATION OF CERULOPLASMIN WITH BIOMARKERS OF CARDIAC REMODELLING AND MYOFIBROSIS: NT-PROBNP, SST2, GALECTIN-3 IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION
    Malek, F.
    Vondrakova, D.
    Dvorak, J.
    Sedlackova, L.
    Andreasova, T.
    Taborsky, L.
    Neuzil, P.
    JOURNAL OF HYPERTENSION, 2016, 34 : E34 - E35
  • [7] NT-proBNP levels in the type 2 diabetes mellitus population: An observational study
    Strelzow, J
    Aydin, C
    Bondy, G
    Tildesley, HD
    DIABETES, 2005, 54 : A521 - A521
  • [8] Testosterone and NT-proBNP in Type 2 Diabetes mellitus infected men.
    Resl, Michael
    Prager, Rudolf
    Pacher, Richard
    Huelsmann, Martin
    Luger, Anton
    Neuhold, Stephanie
    Elhenicky, Marie
    Kautzky-Willer, Alexandra
    Clodi, Martin
    Abrahamian, Heidemarie
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 : S23 - S23
  • [9] Serial monitoring of NT-proBNP predicts heart failure in patients with type 2 diabetes mellitus
    Jarolim, P. Petr
    White, W. B.
    Cannon, C. P.
    Gao, Q.
    Morrow, D. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 30 - 30
  • [10] Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions
    Wei Pan
    Donghui Yang
    Peng Yu
    Huizhen Yu
    BMC Cardiovascular Disorders, 20